Pacific Biosciences Adds $59 Million

Pacific Biosciences, a Menlo Park, Calif.-based DNA gene sequencing company, has raised $59 million in new Series F funding. This brings the round total to $109 million, including a previously-announced $50 million infusion from Gen-Probe Inc. (Nasdaq: GPRO). No new investor information was disclosed, but Pacific Biosciences previously raised around $253 million from Monsanto, the Wellcome Trust, Sutter Hill Ventures, Deerfield Management, Intel Capital, Morgan Stanley, Redmile Group, T. Rowe Price, Mohr Davidow Ventures, Kleiner Perkins Caufield and Byers, Alloy Ventures, Maverick Capital, AllianceBernstein, DAG Ventures, Teachers’ Private Capital and Blackstone Cleantech Venture Partners.

North AmericaUSBriefs